Fernando Velayos

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
    Fernando Velayos
    Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94118, USA
    Clin Gastroenterol Hepatol 5:668-71. 2007
  2. ncbi request reprint Positioning biologic therapy for Crohn's disease and ulcerative colitis
    Fernando S Velayos
    Center for Crohn s and Colitis, University of California, San Francisco, 2330 Post Street Suite 610, San Francisco, California 94115, USA
    Curr Gastroenterol Rep 9:521-7. 2007
  3. doi request reprint A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab
    Fernando S Velayos
    Division of Gastroenterology and Hepatology, University of California, San Francisco, California 94115, USA
    Clin Gastroenterol Hepatol 11:654-66. 2013
  4. doi request reprint Managing risks of neoplasia in inflammatory bowel disease
    Fernando Velayos
    University of California, San Francisco, Center for Crohn s and Colitis, San Francisco, CA 94115, USA
    Curr Gastroenterol Rep 14:174-80. 2012
  5. doi request reprint Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices
    Fernando Velayos
    University of California, San Francisco, Center for Crohn s and Colitis, 2330 Post Street, Suite 610, San Francisco, CA 94116, USA
    Expert Rev Gastroenterol Hepatol 2:817-25. 2008
  6. doi request reprint Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system
    Fernando S Velayos
    Division of Gastroenterology, Department of Internal Medicine, University of California, San Francisco 94115, USA
    Gastroenterology 139:1511-8. 2010
  7. doi request reprint Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis
    Brindusa Truta
    99 Lupine Ave, 503, San Francisco, CA, 94118, USA
    Dig Dis Sci 59:135-45. 2014
  8. pmc Colonoscopy after CT diagnosis of diverticulitis to exclude colon cancer: a systematic literature review
    Victor F Sai
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA
    Radiology 263:383-90. 2012
  9. pmc Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates
    Joel H Rubenstein
    The Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Am J Gastroenterol 104:2222-32. 2009
  10. doi request reprint Colorectal cancer screening and surveillance in the elderly patient
    Lukejohn W Day
    Division of Gastroenterology, San Francisco General Hospital, San Francisco, California, USA
    Am J Gastroenterol 106:1197-206;quiz 1207. 2011

Detail Information

Publications20

  1. ncbi request reprint Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?
    Fernando Velayos
    Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94118, USA
    Clin Gastroenterol Hepatol 5:668-71. 2007
  2. ncbi request reprint Positioning biologic therapy for Crohn's disease and ulcerative colitis
    Fernando S Velayos
    Center for Crohn s and Colitis, University of California, San Francisco, 2330 Post Street Suite 610, San Francisco, California 94115, USA
    Curr Gastroenterol Rep 9:521-7. 2007
    ....
  3. doi request reprint A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab
    Fernando S Velayos
    Division of Gastroenterology and Hepatology, University of California, San Francisco, California 94115, USA
    Clin Gastroenterol Hepatol 11:654-66. 2013
    ..The comparative cost effectiveness of these 2 strategies is unknown. We investigated whether a testing-based strategy is more cost effective than an empiric dose-escalation strategy...
  4. doi request reprint Managing risks of neoplasia in inflammatory bowel disease
    Fernando Velayos
    University of California, San Francisco, Center for Crohn s and Colitis, San Francisco, CA 94115, USA
    Curr Gastroenterol Rep 14:174-80. 2012
    ..Physicians and health professionals may find this information useful for counseling and educating patients as well as for improving patient care...
  5. doi request reprint Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices
    Fernando Velayos
    University of California, San Francisco, Center for Crohn s and Colitis, 2330 Post Street, Suite 610, San Francisco, CA 94116, USA
    Expert Rev Gastroenterol Hepatol 2:817-25. 2008
    ..This article reviews the current practice and emerging technologies for detecting and preventing colon cancer in patients with IBD...
  6. doi request reprint Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system
    Fernando S Velayos
    Division of Gastroenterology, Department of Internal Medicine, University of California, San Francisco 94115, USA
    Gastroenterology 139:1511-8. 2010
    ..Limited data are available on rates of colonoscopy surveillance and factors associated with surveillance...
  7. doi request reprint Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis
    Brindusa Truta
    99 Lupine Ave, 503, San Francisco, CA, 94118, USA
    Dig Dis Sci 59:135-45. 2014
    ..One of the causes of pouch failure after ileal pouch anal anastomosis (IPAA) for ulcerative colitis (UC) is the development of de novo Crohn's disease (CD). Our aim was to clearly define factors associated with post-IPAA CD...
  8. pmc Colonoscopy after CT diagnosis of diverticulitis to exclude colon cancer: a systematic literature review
    Victor F Sai
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA
    Radiology 263:383-90. 2012
    ..To estimate the prevalence of underlying adenocarcinoma of the colon in patients in whom acute diverticulitis was diagnosed at computed tomography (CT) and to compare that to the prevalence of colon cancer in the general population...
  9. pmc Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates
    Joel H Rubenstein
    The Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Am J Gastroenterol 104:2222-32. 2009
    ..Therefore, in patients prescribed 5-ASAs for maintenance of remission, annual surveillance might be overly burdensome and inefficient. We aimed to determine the ideal frequency of surveillance in patients with UC maintained on 5-ASAs...
  10. doi request reprint Colorectal cancer screening and surveillance in the elderly patient
    Lukejohn W Day
    Division of Gastroenterology, San Francisco General Hospital, San Francisco, California, USA
    Am J Gastroenterol 106:1197-206;quiz 1207. 2011
    ..This review addresses the factors unique to colorectal cancer and performing colonoscopy in older adults that are relevant in weighing the risks and benefits of screening and surveillance in this population...
  11. ncbi request reprint Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease
    Fernando S Velayos
    Division of Gastroenterology and Hepatology, University of California, San Francisco, California, USA
    Inflamm Bowel Dis 10:657-60. 2004
    ..Postmarketing surveillance through June of 2001 has identified 10 cases of PCP occurring during treatment with infliximab; 3 patients died...
  12. ncbi request reprint Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study
    Fernando S Velayos
    Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, California, USA
    Gastroenterology 130:1941-9. 2006
    ..The presence of postinflammatory pseudopolyps and use of other anti-inflammatory medications may be important variables that influence risk, but data are sparse...
  13. doi request reprint Challenges in designing a national surveillance program for inflammatory bowel disease in the United States
    Millie D Long
    1Division of Gastroenterology and Hepatology, Departments of Medicine and Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 2Johns Hopkins University School of Medicine, Baltimore, Maryland 3Center for Crohn s and Colitis, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 4Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada 5Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada 6Icahn School of Medicine at Mount Sinai, New York, New York 7Epimad Registry, Epidemiology Unit, Hospital and University Lille Nord de France, Lille, France 8Kaiser Permanente Northern California, Oakland, California 9UCSF Center for Colitis and Crohn s Disease, University of California, San Francisco, San Francisco, California 10Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 11Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Canada 12Portland VA Medical Center, Portland, Oregon 13Alpert Medical School of Brown University, Providence, Rhode Island 14RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina 15Department of Epidemiology, Boston University School of Public Health, Boston, Harvard University
    Inflamm Bowel Dis 20:398-415. 2014
    ..This new model should focus on "surveillance of the burden of disease," including (1) natural history of disease and (2) outcomes and complications of the disease and/or treatments...
  14. doi request reprint Colorectal cancer and the elderly
    Lukejohn W Day
    Division of Gastroenterology, Department of Medicine, San Francisco General Hospital and Trauma Center, 1001 Potrero Avenue, 3D 5, San Francisco, CA 94110, USA Electronic address
    Clin Geriatr Med 30:117-31. 2014
    ..This article explores the evidence for screening and surveillance in the elderly, and addresses key challenges unique to this population. ..
  15. doi request reprint Durability of infliximab dose intensification in Crohn's disease
    Kirk K Lin
    Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
    Dig Dis Sci 57:1013-9. 2012
    ..Dose intensification is a common approach to treat Crohn's disease (CD) patients who lose response to infliximab maintenance therapy. Few studies have reported upon its long-term efficacy or predictors of response...
  16. ncbi request reprint Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies
    Fernando S Velayos
    Division of Gastroenterology and UCSF Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94143, USA
    Am J Gastroenterol 100:1345-53. 2005
    ..We performed a systematic review with metaanalysis of observational studies evaluating the association between 5-ASA use and colorectal cancer (CRC) or dysplasia among patients with ulcerative colitis...
  17. ncbi request reprint Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines
    Fernando S Velayos
    Division of Gastroenterology and Colorectal Cancer Prevention Program, University of California, San Francisco, CA, USA
    Am J Gastroenterol 100:1143-9. 2005
    ..We sought to determine the rate of MSI in adenomas removed from individuals under 40 yr of age over a 5-yr period in a university general gastroenterology practice...
  18. ncbi request reprint Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis
    Gary R Lichtenstein
    Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Rev Gastroenterol Disord 8:21-30; quiz 31-2. 2008
    ..Novel formulations of mesalamine and newly devised, high-dose regimens offer additional therapeutic options and may lead to improved treatment adherence, longer-lasting periods of remission, and enhanced patient well-being...
  19. ncbi request reprint Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota
    Tine Jess
    Department of Medical Gastroenterology, Herlev University Hospital, Herlev, Denmark
    Inflamm Bowel Dis 12:669-76. 2006
    ....
  20. ncbi request reprint Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota
    Tine Jess
    Department of Medical Gastroenterology, Herlev University Hospital, Herlev, Denmark
    Gastroenterology 130:1039-46. 2006
    ..We estimated the risk for small-bowel and colorectal cancer in a population-based cohort of 692 inflammatory bowel disease patients from Olmsted County, Minnesota, from 1940 to 2001...